GENERALIZED MYASTHENIA GRAVIS
Clinical trials for GENERALIZED MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for GENERALIZED MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for rare Muscle-Weakening disease
Disease control OngoingThis study tests a new medicine called ALXN1720 for adults with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see if the drug improves daily activities and muscle strength compared to a placebo. About 261 participants with specific antibod…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
New hope for kids with rare muscle disease: daily shot tested for Long-Term safety
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of a daily injection called zilucoplan in children with a rare muscle-weakening disease called generalized myasthenia gravis. It includes up to 8 children who have already completed a previous study. The goal is to see if the drug is safe …
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 26, 2026 05:02 UTC
-
New study tests Long-Term safety of efgartigimod for kids with rare muscle disease
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of a drug called efgartigimod in children with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. About 12 children who were in earlier studies will continue to receive the drug either through a vein or as a shot…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 26, 2026 05:00 UTC
-
New drug shows promise for rare Muscle-Weakening disease
Disease control OngoingThis study tests a drug called batoclimab in 240 adults with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see if it can improve daily activities and reduce symptoms. Participants receive either the drug or a placebo as a shot under the sk…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated May 26, 2026 04:59 UTC
-
New hope for myasthenia gravis: Long-Term drug study underway
Disease control OngoingThis study looks at the long-term safety and effectiveness of the drug zilucoplan in people with generalized myasthenia gravis, a chronic muscle weakness condition. About 200 adults who already completed a prior zilucoplan study will receive the drug for an extended period. The g…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New hope for kids with rare muscle-weakening disease: drug trial underway
Disease control OngoingThis study tests a drug called ravulizumab in 12 children aged 6 to 18 with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see how the drug works in the body, how safe it is, and whether it helps control symptoms like trouble moving or brea…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New drug duo aims to ease muscle weakness in myasthenia gravis patients
Disease control OngoingThis study tests two experimental drugs, pozelimab and cemdisiran, alone or together, in 288 adults with generalized myasthenia gravis (gMG), a disease that causes muscle weakness and fatigue. The goal is to see if these drugs improve daily activities and muscle strength. Partici…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New drug hope for rare Muscle-Weakening disease
Disease control OngoingThis study tests an investigational drug called efgartigimod given through a vein for adults with generalized myasthenia gravis (gMG) who do not have the usual acetylcholine receptor antibody. The goal is to see if it improves daily activities and muscle strength compared to a pl…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
New drug trial aims to ease rare Muscle-Weakening disease in kids
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of a drug called rozanolixizumab in children aged 2 and older with generalized myasthenia gravis, a condition that causes muscle weakness. Participants will receive additional 6-week treatment cycles. The goal is to monitor serious side ef…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 18, 2026 12:07 UTC